Mobiphar SRL
3.3 FTEThe score of Mobiphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +90 % Total assets +98 % Headcount (avg FTE) +120 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mobiphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 133,416 € | ||||
| Equity | 960,758 € | ||||
| Cash | 224,487 € | ||||
| EBITDA | 306,714 € | ||||
| Total assets | €1.62m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
Mobiphar's financial analysis
- Solvency59.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mobiphar
Mobiphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0824.257.894
- VAT number
- BE0824257894
- Peppol
- Registered · 0208:0824257894 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Mar 2010
- Registered office
- 8210 Zedelgem
- Size
- Micro · 3.3 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mobiphar (SRL) has been based in Zedelgem since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 133,416 € and equity of 960,758 €; its revenue is not published. With 3.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 59.4%, above the median of its sector (44.2%).
Companies similar to Mobiphar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Vandromme Retail sale of pharmaceutical products Wevelgem · balance sheet €1.35m
- Pharmacie Martin-Cosse Retail sale of pharmaceutical products Andenne · balance sheet €2.15m
- Sodyss Retail sale of pharmaceutical products Diest · balance sheet €1.02m
- Degrofarm Retail sale of pharmaceutical products Deinze · balance sheet €1.47m
- Omnicare Farma Dam Retail sale of pharmaceutical products Lokeren · balance sheet €1.25m
- Biesemans-Cornille Retail sale of pharmaceutical products Bruges · balance sheet €1.41m
- Frapeja Invest Retail sale of pharmaceutical products Ghent · balance sheet €2.36m
- Strybol Trui Apotheek Retail sale of pharmaceutical products Bruges · balance sheet 397,630 €
Frequently asked questions about Mobiphar
What is the revenue of Mobiphar?
Mobiphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mobiphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0824257894 for Mobiphar, if the company is VAT-registered. Its company number (CBE) is 0824.257.894.
Where is the registered office of Mobiphar?
According to the CBE register, the registered office of Mobiphar is in 8210 Zedelgem.
What is the equity of Mobiphar?
At the close of the 2025 financial year, the equity of Mobiphar amounts to 960,758 €, a solvency of 59.4% of total assets.
How many people work at Mobiphar?
3.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Mobiphar?
The register lists 1 active mandates at Mobiphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mobiphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →